316 related articles for article (PubMed ID: 10197730)
1. CD69, CD25, and HLA-DR activation antigen expression on CD3+ lymphocytes and relationship to serum TNF-alpha, IFN-gamma, and sIL-2R levels in aging.
Rea IM; McNerlan SE; Alexander HD
Exp Gerontol; 1999 Jan; 34(1):79-93. PubMed ID: 10197730
[TBL] [Abstract][Full Text] [Related]
2. In vivo CD3+CD25+ lymphocyte subpopulation is down-regulated without increased serum-soluble interleukin-2 receptor (sIL-2R) by gonadotropin releasing hormone agonist (GnRH-a).
Ho HN; Wu MY; Chen HF; Chao KH; Yang YS; Huang SC; Lee TY; Gill TJ
Am J Reprod Immunol; 1995 Jan; 33(1):134-9. PubMed ID: 7619228
[TBL] [Abstract][Full Text] [Related]
3. The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I.
Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
Folia Histochem Cytobiol; 2011; 49(4):579-92. PubMed ID: 22252752
[TBL] [Abstract][Full Text] [Related]
4. Does immune activation continue during an attack-free period in familial Mediterranean fever?
Musabak U; Sengul A; Oktenli C; Pay S; Yesilova Z; Kenar L; Sanisoglu SY; Inal A; Tuzun A; Erdil A; Bagci S
Clin Exp Immunol; 2004 Dec; 138(3):526-33. PubMed ID: 15544632
[TBL] [Abstract][Full Text] [Related]
5. Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma.
Van den Hove LE; Van Gool SW; Van Poppel H; Baert L; Coorevits L; Van Damme B; Ceuppens JL
Clin Exp Immunol; 1997 Sep; 109(3):501-9. PubMed ID: 9328129
[TBL] [Abstract][Full Text] [Related]
6. Acute T-cell activation is detectable in unstable angina.
Neri Serneri GG; Prisco D; Martini F; Gori AM; Brunelli T; Poggesi L; Rostagno C; Gensini GF; Abbate R
Circulation; 1997 Apr; 95(7):1806-12. PubMed ID: 9107167
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of the immunological phenomena and relationship with clinicopathological characteristics of the tumor--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ lymphocytes in squamous cell laryngeal carcinoma. Part II.
Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
Folia Histochem Cytobiol; 2011; 49(4):593-603. PubMed ID: 22252753
[TBL] [Abstract][Full Text] [Related]
8. Coexpression of CD69 and HLADR activation markers on synovial fluid T lymphocytes of patients affected by rheumatoid arthritis: a three-colour cytometric analysis.
Afeltra A; Galeazzi M; Sebastiani GD; Ferri GM; Caccavo D; Addessi MA; Marcolongo R; Bonomo L
Int J Exp Pathol; 1997 Oct; 78(5):331-6. PubMed ID: 9462230
[TBL] [Abstract][Full Text] [Related]
9. CD69, HLA-DR and the IL-2R identify persistently activated T cells in psoriasis vulgaris lesional skin: blood and skin comparisons by flow cytometry.
Ferenczi K; Burack L; Pope M; Krueger JG; Austin LM
J Autoimmun; 2000 Feb; 14(1):63-78. PubMed ID: 10648117
[TBL] [Abstract][Full Text] [Related]
10. Expression of activation antigens CD69, HLA-DR, interleukin-2 receptor-alpha (IL-2R alpha) and IL-2R beta on T cells of human decidua at an early stage of pregnancy.
Saito S; Nishikawa K; Morii T; Narita N; Enomoto M; Ichijo M
Immunology; 1992 Apr; 75(4):710-2. PubMed ID: 1592443
[TBL] [Abstract][Full Text] [Related]
11. Increased CD69 and human leukocyte antigen-DR expression on T lymphocytes in insulin-dependent diabetes mellitus of long standing.
Gessl A; Waldhäusl W
J Clin Endocrinol Metab; 1998 Jun; 83(6):2204-9. PubMed ID: 9626161
[TBL] [Abstract][Full Text] [Related]
12. Defective clonogenic potential of CD8+ T lymphocytes in patients with AIDS. Expansion in vivo of a nonclonogenic CD3+CD8+DR+CD25- T cell population.
Pantaleo G; Koenig S; Baseler M; Lane HC; Fauci AS
J Immunol; 1990 Mar; 144(5):1696-704. PubMed ID: 2137842
[TBL] [Abstract][Full Text] [Related]
13. [The expression of activation markers on decidual lymphocytes in the first trimester of pregnancy].
Slukvin II; Chernyshov VP; Merkulova AV
Biull Eksp Biol Med; 1993 Oct; 116(10):414-6. PubMed ID: 8117970
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric assessment of human peripheral blood mononuclear cells in response to a coccidioidal antigen.
Ampel NM; Christian L
Med Mycol; 2000 Apr; 38(2):127-32. PubMed ID: 10817229
[TBL] [Abstract][Full Text] [Related]
15. Study of T-cell activation in type I diabetic patients and pre-type I diabetic subjects by cytometric analysis: antigen expression defect in vitro.
Giordano C; De Maria R; Todaro M; Stassi G; Mattina A; Richiusa P; Galluzzo G; Pantó F; Galluzzo A
J Clin Immunol; 1993 Jan; 13(1):68-78. PubMed ID: 8095271
[TBL] [Abstract][Full Text] [Related]
16. [Lymphocyte activation markers in patients with ovarian cancer].
Nowicka A; Rogala E; Bednarek W; Barczyński B; Wertel I; Piekarczyk W; Kotarski J
Ginekol Pol; 2012 Oct; 83(10):737-43. PubMed ID: 23383558
[TBL] [Abstract][Full Text] [Related]
17. Elevated CD69 expression on naive peripheral blood T-cells in hyperthyroid Graves' disease and autoimmune thyroiditis: discordant effect of methimazole on HLA-DR and CD69.
Gessl A; Waldhäusl W
Clin Immunol Immunopathol; 1998 May; 87(2):168-75. PubMed ID: 9614932
[TBL] [Abstract][Full Text] [Related]
18. CD69+ and HLA-DR+ activation antigens on peripheral blood lymphocyte populations in metastatic breast and ovarian cancer patients: correlations with survival following active specific immunotherapy.
Yacyshyn MB; Poppema S; Berg A; MacLean GD; Reddish MA; Meikle A; Longenecker BM
Int J Cancer; 1995 May; 61(4):470-4. PubMed ID: 7538976
[TBL] [Abstract][Full Text] [Related]
19. Selective role for the p55 Kd TNF-alpha receptor in immune unresponsiveness induced by an acute viral encephalitis.
Camelo S; Lafage M; Galelli A; Lafon M
J Neuroimmunol; 2001 Feb; 113(1):95-108. PubMed ID: 11137581
[TBL] [Abstract][Full Text] [Related]
20. Characterization of cytokine production, screening of lymphocyte subset patterns and in vitro apoptosis in healthy and Alzheimer's Disease (AD) individuals.
Lombardi VR; García M; Rey L; Cacabelos R
J Neuroimmunol; 1999 Jun; 97(1-2):163-71. PubMed ID: 10408971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
